Low-Dose Klonopin Gets FDA Generic Approval Nod
Published Date: 2/23/2026
Notice
Summary
The FDA has decided that Klonopin tablets in 0.125 mg and 0.25 mg strengths were not taken off the market because of safety or effectiveness problems. This means generic drug makers can now apply to sell their versions of these Klonopin tablets, as long as they meet all other rules. Patients and pharmacies could see more affordable options soon, with no safety worries holding things back.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Generic Klonopin Applications Allowed
The FDA determined on February 23, 2026, that KLONOPIN (clonazepam) tablets, 0.125 mg and 0.25 mg, were not withdrawn from sale for reasons of safety or effectiveness. That determination allows generic drug makers to submit abbreviated new drug applications (ANDAs) for those two strengths and for FDA to approve such ANDAs if they meet all other legal and regulatory requirements, which could lead to more affordable options for patients and pharmacies.
FDA Confirms No Safety Withdrawal
After reviewing a citizen petition (dated June 20, 2025) and Agency records, the FDA found no data showing that KLONOPIN (clonazepam) tablets, 0.125 mg and 0.25 mg, were withdrawn from sale for reasons of safety or effectiveness. The Agency also reviewed relevant literature and postmarketing adverse event information and will continue to list these strengths in the Orange Book's Discontinued Drug Product List as discontinued for reasons other than safety or effectiveness.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in